← 產業報告目錄
Derma Fillers Market by Brand (Juvederm, Sculptra, Radiesse), Product (Hyaluronic, Collagen, PLLA), Procedure (Skin Rejuvenation, Scar Removal, Face & Body Contouring), End User (Dermatology Clinic, Beauty Centers, Medical Spa) - Global Forecast to 2030
授權報價
| Single User Licence | $4,950 USD |
| Multi User Licence | $6,650 USD |
| Corporate User Licence | $8,150 USD |
| Global User Licence | $10,000 USD |
報告摘要
The derma fillers market is expected to experience significant growth, increasing from USD 4.1 billion in 2025 to USD 7.3 billion by 2030.
This growth is fueled by various factors, including demand for minimally invasive aesthetic procedures. Social media trends have normalized and mythologized the use of dermal fillers, particularly among Millennials and Generation Z. Plus, the prevalence of age-related skin issues, such as wrinkles and loss of volume, is stimulating the need for aesthetic treatments.
Fillers are being used for added indications (e.g., jawline, chin, hands) and the demand for customized treatments.
Continuous R&D and improved formulations (e.g., biodegradable and long-lasting injectables) and injection techniques have assured the long-term safety of fillers, making them even more appealing to practitioners and patients. These trends will continue to spur the growth of the global market.
“Natural dermal fillers dominated the market in 2024.”
Natural dermal fillers, particularly those based on hyaluronic acid (HA), collagen, and other biodegradable, biocompatible materials, lead the market because they are highly biocompatible and have little risk of allergic reactions or side effects, all while being reversible as well. The worldwide trend toward less invasive aesthetic procedures for aesthetic improvements is a significant contributor to growth, whereby natural dermal fillers provide a non-surgical alternative for facial rejuvenation, wrinkle correction, and volume restoration. Natural dermal fillers are generation and consumer-driven, sourcing from consumer demand for safety, biocompatibility, and a natural-looking result, as well as consumer trends toward minimally invasive procedures, customizable treatments, and the popularity of social media and youth culture. Hyaluronic acid and other biodegradable fillers dominate natural dermal fillers and highlight consumer priorities, as natural fillers remain the preferred choice in the fast-growing derma fillers market.
“The dermatology clinics & hospitals segment held the largest share of the derma fillers market in 2024.”
Dermatology clinics & hospitals are the primary end user in the derma fillers market, they are being fueled by increasing aesthetic demand with rising consumer interest in facial aesthetics and youthful appearance, product innovation, an expanding treatment indicator where clinics and hospitals are expanding their offerings to facial contouring, volume restoration, lip augmentation, or even hand rejuvenation, based on new product approvals and continuous patient needs. Other influences contributing to the performance, expertise, professional alliances and collaborations, and the socioeconomic environment have allowed procedures to be realized by patients and professionals alike. These drivers collectively provide domain and procedural growth and a lot of uptake in dermal filler procedures in both the clinics and hospital settings.
“The Asia Pacific region is expected to register the highest CAGR in the derma fillers market during the forecast period.”
The Asia Pacific (APAC) region is one of the fastest emerging markets for dermal fillers, with growth driven by an unparalleled combination of demographic, economic, cultural, and technological factors. Demographic changes especially rising awareness and acceptance of aesthetic procedures (in particular among the younger and middle-aged consumer base), economic growth - resulting in a larger middle class with greater spending capacity, which makes non-invasive cosmetic skin treatment options accessible to a much wider audience, R&D and product releases of next-generation fillers which have significantly improved safety, efficacy and longevity, are all contributing factors leading to the growth of the APAC dermal fillers market. The exploding beauty consciousness, social media, continuous economic growth, aging populations, sustained innovation, medical tourism, supportive government policies, and developing healthcare infrastructures represent some of the major accelerators to the APAC dermal fillers market. The APAC derma fillers market is a large and very competitive market undergoing constant and rapid growth, driven by innovation.
A breakdown of the primary participants referred to for this report is provided below:
• By Company: Tier 1 (35%), Tier 2 (45%), and Tier 3 (20%)
• By Designation: C-level Executives (35%), Director-level Executives (25%), and Others (40%)
• By Region: North America (40%), Europe (30%), Asia Pacific (20%), Latin America (5%), and the Middle East & Africa (5%)
Prominent players in the derma fillers market include Allergan Aesthetics (US), Merz Pharma KGaA (Germany), Galderma (Switzerland), Sinclair Pharma (UK), Bioxis Pharmaceutical (France), Suneva Medical (US), Croma Pharma (Austria), Prollenium Medical Technologies (Canada), Dermax Med (China), Zimmer Aesthetics (Germany), Marllor Biomedical (Italy), MEDYTOX (South Korea), Revance Therapeutic (US), Dr. Korman Pharma (Israel), CGBio Co., Ltd. (South Korea), REGEN Biotech (UK), and BioScience GmbH (Germany), among others.
Research Coverage
• The report studies the derma fillers market based on brand, product, procedure, end user, and region.
• The report analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth.
• The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.
• The report studies micro markets with respect to their growth trends, prospects, and contributions to the global derma fillers market.
• The report forecasts the revenue of market segments with respect to five major regions.
Key Benefits of Buying this Report
This report is valuable for both new and current players in the market, offering essential information to identify potential investment opportunities. It provides a comprehensive overview of both major and minor players, facilitating effective risk analysis and informed investment decisions. The report includes precise segmentation based on end users and geographical regions, offering detailed insights into niche market segments. Additionally, it highlights key trends, growth drivers, challenges, and opportunities, supporting strategic decision-making through a balanced analysis.
Through this report, readers get insightful views into the following parameters:
• Analysis of key drivers (Increasing demand for non-invasive aesthetic treatments, continued R&D has grown the sophistication of products, i.e., biodegradable longer-lasting fillers, improved injecting techniques), restraints (Cost barriers to treatment and the need for repeated treatments due to temporary nature of most derma fillers, concerns about adverse effects or complications can also impede market growth), opportunities (Exploration of biodegradable and bioresorbable fillers, potential for fillers to be used in conjunction with other aesthetic treatments, such as the use of botulinum toxin and laser therapy), challenges (the possibility of complications, such as vascular occlusion, granulomas or allergic reactions, can damage patient trust in procedures and also reputation and therefore negatively impact the market), relating to the growth of the derma fillers market.
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product & service launches in the derma fillers market.
• Market Development: Comprehensive information about lucrative markets – the report analyzes the derma fillers market across varied regions.
• Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the derma fillers market
• Competitive Assessment: A comprehensive analysis of market share, product offerings, and leading strategies of major players, such as Allergan Aesthetics (US), Merz Pharma KGaA (Germany), Galderma (Switzerland), Croma Pharma (Austria), Sinclair Pharma (UK), Bioxis Pharmaceutical (France), Suneva Medical (US), Prollenium Medical Technologies (Canada), Dermax Med (China), Zimmer Aesthetics (Germany), Marllor Biomedical (Italy), MEDYTOX (South Korea), Revance Therapeutic (US), Dr. Korman Pharma (Israel), CGBio Co., Ltd. (South Korea), REGEN Biotech (UK), and BioScience GmbH (Germany).
目錄 Table of Contents
1 INTRODUCTION 23
1.1 STUDY OBJECTIVES 23
1.2 MARKET DEFINITION 23
1.3 STUDY SCOPE 24
1.3.1 MARKETS COVERED AND REGIONAL SCOPE 24
1.3.2 INCLUSIONS AND EXCLUSIONS 25
1.3.3 YEARS CONSIDERED 25
1.4 CURRENCY CONSIDERED 26
1.5 STAKEHOLDERS 26
2 RESEARCH METHODOLOGY 27
2.1 RESEARCH DATA 27
2.1.1 SECONDARY RESEARCH 28
2.1.1.1 Key secondary sources 28
2.1.1.2 Key data from secondary sources 29
2.1.1.3 Objectives of secondary research 30
2.2 MARKET SIZE ESTIMATION 33
2.2.1 BOTTOM-UP APPROACH 35
2.2.1.1 Approach 1: Company revenue estimation 35
2.2.1.2 Approach 2: Customer-based market estimation 36
2.2.1.3 Approach 3: Primary interviews 37
2.2.2 TOP-DOWN APPROACH 37
2.3 GROWTH FORECAST 38
2.4 DATA TRIANGULATION 41
2.5 RESEARCH ASSUMPTIONS 42
2.6 RESEARCH LIMITATIONS 42
2.7 RISK ANALYSIS 42
3 EXECUTIVE SUMMARY 43
4 PREMIUM INSIGHTS 46
4.1 DERMA FILLERS MARKET OVERVIEW 46
4.2 NORTH AMERICA: DERMA FILLERS MARKET, BY PROCEDURE,
2025 VS. 2030 (USD MILLION) 47
4.3 EUROPE: DERMA FILLERS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 47
4.4 DERMA FILLERS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 48
5 MARKET OVERVIEW 49
5.1 INTRODUCTION 49
5.2 MARKET DYNAMICS 49
5.2.1 DRIVERS 50
5.2.1.1 Increasing adoption of minimally invasive and non-invasive aesthetic procedures 50
5.2.1.2 Growing demand for aesthetic treatments among elderly and men 50
5.2.1.3 Rising acceptance and normalization of fillers among millennials and Gen Z fueled by social media 51
5.2.2 RESTRAINTS 51
5.2.2.1 Risk of infection and safety concerns 51
5.2.2.2 Complex regulatory framework and compliance standards 52
5.2.3 OPPORTUNITIES 52
5.2.3.1 Growth opportunities in emerging markets 52
5.2.3.2 Launch of new technologies and products 53
5.2.4 CHALLENGES 53
5.2.4.1 High cost of treatments and devices 53
5.2.4.2 Social and cultural barriers 53
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 54
5.4 PRICING ANALYSIS 54
5.4.1 AVERAGE SELLING PRICE TREND, BY PRODUCT 55
5.4.2 AVERAGE SELLING PRICE TREND, BY KEY PLAYER 56
5.4.3 AVERAGE SELLING PRICE TREND, BY REGION 57
5.5 VALUE CHAIN ANALYSIS 59
5.5.1 RESEARCH & DEVELOPMENT 60
5.5.2 RAW MATERIAL PROCUREMENT AND PRODUCT MANUFACTURING 60
5.5.3 DISTRIBUTION, MARKETING & SALES, AND AFTER-SALES SERVICES 60
5.6 SUPPLY CHAIN ANALYSIS 61
5.6.1 PROMINENT COMPANIES 61
5.6.2 SMALL AND MEDIUM-SIZED ENTERPRISES 61
5.6.3 END USERS 61
5.7 ECOSYSTEM ANALYSIS 62
5.8 INVESTMENT AND FUNDING SCENARIO 63
5.9 TECHNOLOGY ANALYSIS 64
5.9.1 KEY TECHNOLOGIES 64
5.9.1.1 Advanced Hyaluronic Acid (HA) cross-linking 64
5.9.1.2 Polymethylmethacrylate (PMMA) fillers 64
5.9.1.3 Bio-stimulatory fillers 64
5.9.2 COMPLEMENTARY TECHNOLOGIES 65
5.9.2.1 Laser resurfacing 65
5.9.2.2 Microneedling 65
5.9.3 ADJACENT TECHNOLOGIES 65
5.9.3.1 3D imaging and AI-based facial mapping 65
5.10 PATENT ANALYSIS 66
5.11 TRADE ANALYSIS 68
5.11.1 IMPORT SCENARIO (HS CODE 330499) 68
5.11.2 EXPORT SCENARIO (HS CODE 330499) 69
5.12 KEY CONFERENCES AND EVENTS, 2025–2026 70
5.13 CASE STUDY ANALYSIS 71
5.13.1 COMMERCIAL PARTNERSHIPS FOR AESTHETIC PRODUCT SALES 71
5.13.2 DIVERSIFICATION OF BUSINESS TO MEET CUSTOMER DEMANDS 71
5.13.3 COLLABORATIONS WITH SMES FOR STREAMLINING LASER-BASED DEVICES 71
5.14 REGULATORY LANDSCAPE 72
5.14.1 REGULATORY ANALYSIS 72
5.14.1.1 North America 72
5.14.1.1.1 US 72
5.14.1.1.2 Canada 72
5.14.1.2 Europe 73
5.14.1.2.1 UK 73
5.14.1.2.2 France 74
5.14.1.2.3 Germany 74
5.14.1.3 Asia Pacific 74
5.14.1.3.1 Japan 74
5.14.1.3.2 India 75
5.14.1.4 Rest of the World 75
5.14.1.4.1 Brazil 75
5.14.1.4.2 UAE 75
5.14.2 REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 76
5.15 PORTER’S FIVE FORCES ANALYSIS 78
5.15.1 BARGAINING POWER OF SUPPLIERS 79
5.15.2 BARGAINING POWER OF BUYERS 79
5.15.3 THREAT OF NEW ENTRANTS 79
5.15.4 THREAT OF SUBSTITUTES 79
5.15.5 INTENSITY OF COMPETITIVE RIVALRY 79
5.16 KEY STAKEHOLDERS AND BUYING CRITERIA 79
5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS 80
5.16.2 BUYING CRITERIA 81
5.17 REIMBURSEMENT SCENARIO 82
5.18 UNMET NEEDS AND KEY PAIN POINTS 82
5.19 IMPACT OF AI ON DERMA FILLERS MARKET 83
5.19.1 INTRODUCTION 83
5.19.2 MARKET POTENTIAL OF AI ON DERMA FILLERS ECOSYSTEM 83
5.19.3 AI USE CASES 83
5.19.4 KEY COMPANIES IMPLEMENTING AI 84
5.19.5 FUTURE OF GENERATIVE AI IN DERMA FILLERS MARKET 84
5.20 US TARIFF 2025 84
5.20.1 INTRODUCTION 84
5.20.2 KEY TARIFF RATES 85
5.20.3 PRICE IMPACT ANALYSIS 85
5.20.4 IMPACT ON COUNTRY/REGION 86
5.20.4.1 US 86
5.20.4.2 Europe 86
5.20.4.3 Asia Pacific 86
5.20.5 IMPACT ON END-USE INDUSTRIES 86
6 DERMA FILLERS MARKET, BY BRAND 88
6.1 INTRODUCTION 89
6.2 JUVEDERM 89
6.2.1 WIDE INDICATION COVERAGE AND GLOBAL REACH TO CONTRIBUTE TO GROWTH 89
6.3 RESTYLANE 90
6.3.1 FASTER ONSET DURATION AND LONG-LASTING EFFECT TO ENCOURAGE GROWTH 90
6.4 RHA COLLECTION 90
6.4.1 GROWING DESIRE FOR NATURAL EXPRESSIONS TO BOOST MARKET 90
6.5 SCULPTRA 90
6.5.1 INCREASED ADOPTION OF SCULPTRA AMONG ADVANCED INJECTORS TO BOLSTER GROWTH 90
6.6 RADIESSE 91
6.6.1 STABLE SUCCESS RATES AND DESIRED RESULTS TO SPUR GROWTH 91
6.7 LANLUMA 91
6.7.1 EXPANDED USE CASES IN BODY CONTOURING APPLICATIONS TO INTENSIFY GROWTH 91
6.8 BELLAFILL 92
6.8.1 USE OF BELLAFILL FOR TREATING DEEP ACNE SCARS AND NASOLABIAL FOLDS TO FOSTER GROWTH 92
6.9 OTHER BRANDS 92
7 DERMA FILLERS MARKET, BY PRODUCT TYPE 93
7.1 INTRODUCTION 94
7.2 NATURAL DERMAL FILLERS 94
7.2.1 HYALURONIC ACID FILLERS 98
7.2.1.1 Wide clinical acceptance and safety profile to aid growth 98
7.2.2 COLLAGEN FILLERS 98
7.2.2.1 Ability to provide structural support and improved skin texture to boost market 98
7.3 SYNTHETIC DERMAL FILLERS 99
7.3.1 CALCIUM HYDROXYLAPATITE (CAHA) FILLERS 103
7.3.1.1 Long-term collagen stimulation property to augment growth 103
7.3.2 POLY-L-LACTIC ACID (PLLA) FILLERS 103
7.3.2.1 Increasing desire for natural, progressive rejuvenation to stimulate growth 103
7.3.3 POLYMETHYL METHACRYLATE (PMMA) FILLERS 104
7.3.3.1 Long-lasting structural correction ability to favor growth 104
7.3.4 POLYNUCLEOTIDE FILLERS 105
7.3.4.1 Rising preference for skin revitalization procedures to fuel market 105
7.3.5 OTHER SYNTHETIC FILLERS 106
8 DERMA FILLERS MARKET, BY PROCEDURE 107
8.1 INTRODUCTION 108
8.2 SKIN REJUVENATION 108
8.2.1 INCREASING ACCEPTANCE AND REPEATABILITY OF SKIN PROCEDURES TO FACILITATE GROWTH 108
8.3 FACE & BODY CONTOURING 109
8.3.1 RISING NUMBER OF FACIAL AND BODY CONTOURING-RELATED PROCEDURES TO PROMOTE GROWTH 109
8.4 LIP AUGMENTATION 110
8.4.1 NEED FOR REPETITIVE CYCLES TO MAINTAIN DESIRED LOOK TO PROPEL MARKET 110
8.5 OTHER PROCEDURES 111
9 DERMA FILLERS MARKET, BY END USER 112
9.1 INTRODUCTION 113
9.2 DERMATOLOGY CLINICS & HOSPITALS 113
9.2.1 RISING TREND OF MEDICAL TOURISM AND PLASTIC SURGERY TO SUPPORT GROWTH 113
9.3 BEAUTY CENTERS 114
9.3.1 GROWING INCLINATION TOWARD CUSTOMIZED TREATMENT TO DRIVE MARKET 114
9.4 MEDICAL SPAS 115
9.4.1 INCREASING FOCUS ON CONVENIENCE, TREATMENT FLEXIBILITY,
AND COST SAVING TO SPUR GROWTH 115
9.5 OTHER END USERS 116
10 DERMA FILLERS MARKET, BY REGION 117
10.1 INTRODUCTION 118
10.2 NORTH AMERICA 119
10.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 120
10.2.2 US 122
10.2.2.1 Rising geriatric population to spur growth 122
10.2.3 CANADA 123
10.2.3.1 Preference of aging individuals to reduce aging signs to promote growth 123
10.3 EUROPE 124
10.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 126
10.3.2 GERMANY 127
10.3.2.1 Large consumer base to expedite growth 127
10.3.3 UK 128
10.3.3.1 Increasing volume-enhancement treatments to support growth 128
10.3.4 FRANCE 129
10.3.4.1 Favorable demographics and increased acceptance of non-surgical procedures to aid growth 129
10.3.5 ITALY 130
10.3.5.1 Growing acceptance of minimally invasive procedures to fuel market 130
10.3.6 SPAIN 131
10.3.6.1 Increasing availability of safe and minimally invasive treatments to augment growth 131
10.3.7 REST OF EUROPE 132
10.4 ASIA PACIFIC 133
10.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 134
10.4.2 JAPAN 137
10.4.2.1 Growing trend of volume restoration and wrinkle correction to boost market 137
10.4.3 CHINA 138
10.4.3.1 Surging demand for aesthetic procedures to accelerate growth 138
10.4.4 INDIA 138
10.4.4.1 Rapid urbanization and proliferation of clinics to stimulate growth 138
10.4.5 AUSTRALIA 139
10.4.5.1 Rising safety standards for non-surgical cosmetic procedures to encourage growth 139
10.4.6 SOUTH KOREA 140
10.4.6.1 Robust medical infrastructure to speed up growth 140
10.4.7 REST OF ASIA PACIFIC 140
10.5 LATIN AMERICA 141
10.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 143
10.5.2 BRAZIL 144
10.5.2.1 Cultural normalization of aesthetic treatments to contribute to growth 144
10.5.3 MEXICO 145
10.5.3.1 Increasing inflow of medical tourists to sustain growth 145
10.5.4 REST OF LATIN AMERICA 146
10.6 MIDDLE EAST & AFRICA 147
10.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 147
10.6.2 GCC COUNTRIES 150
10.6.2.1 Booming aesthetic tourism sector to facilitate growth 150
10.6.3 REST OF MIDDLE EAST & AFRICA 151
11 COMPETITIVE LANDSCAPE 152
11.1 INTRODUCTION 152
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 152
11.3 REVENUE ANALYSIS, 2020–2024 154
11.4 MARKET SHARE ANALYSIS, 2024 155
11.4.1 NATURAL DERMA FILLERS MARKET SHARE 155
11.4.2 SYNTHETIC DERMAL FILLERS MARKET SHARE 155
11.5 COMPANY VALUATION AND FINANCIAL METRICS 158
11.6 BRAND/PRODUCT COMPARISON 159
11.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 159
11.7.1 STARS 159
11.7.2 EMERGING LEADERS 160
11.7.3 PERVASIVE PLAYERS 160
11.7.4 PARTICIPANTS 160
11.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 161
11.7.5.1 Company footprint 161
11.7.5.2 Region footprint 162
11.7.5.3 Product type footprint 163
11.7.5.4 Procedure footprint 164
11.7.5.5 End-user footprint 165
11.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 165
11.8.1 PROGRESSIVE COMPANIES 165
11.8.2 RESPONSIVE COMPANIES 165
11.8.3 DYNAMIC COMPANIES 166
11.8.4 STARTING BLOCKS 166
11.8.5 COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 167
11.8.5.1 Detailed list of key startups/SMEs 167
11.8.5.2 Competitive benchmarking of key startups/SMEs 168
11.9 COMPETITIVE SCENARIO 169
11.9.1 PRODUCT LAUNCHES AND APPROVALS 169
11.9.2 DEALS 170
12 COMPANY PROFILES 171
12.1 KEY PLAYERS 171
12.1.1 ABBVIE INC. 171
12.1.1.1 Business overview 171
12.1.1.2 Products offered 172
12.1.1.3 Recent developments 173
12.1.1.3.1 Product launches and approvals 173
12.1.1.4 MnM view 173
12.1.1.4.1 Key strengths 173
12.1.1.4.2 Strategic choices 173
12.1.1.4.3 Weaknesses and competitive threats 174
12.1.2 GALDERMA 175
12.1.2.1 Business overview 175
12.1.2.2 Products offered 176
12.1.2.3 Recent developments 177
12.1.2.3.1 Product launches and approvals 177
12.1.2.3.2 Deals 177
12.1.2.3.3 Expansions 178
12.1.2.4 MnM view 178
12.1.2.4.1 Key strengths 178
12.1.2.4.2 Strategic choices 178
12.1.2.4.3 Weaknesses and competitive threats 178
12.1.3 MERZ PHARMA 179
12.1.3.1 Business overview 179
12.1.3.2 Products offered 180
12.1.3.3 Recent developments 180
12.1.3.3.1 Expansions 181
12.1.3.4 MnM view 182
12.1.3.4.1 Key strengths 182
12.1.3.4.2 Strategic choices 182
12.1.3.4.3 Weaknesses and competitive threats 182
12.1.4 SILCLAIR PHARMA 183
12.1.4.1 Business overview 183
12.1.4.2 Products offered 184
12.1.4.3 MnM view 184
12.1.4.3.1 Key strengths 184
12.1.4.3.2 Strategic choices 184
12.1.4.3.3 Weaknesses and competitive threats 184
12.1.5 REVANCE 185
12.1.5.1 Business overview 185
12.1.5.2 Products offered 185
12.1.5.3 Recent developments 186
12.1.5.3.1 Product launches and approvals 186
12.1.5.3.2 Deals 186
12.1.5.4 MnM view 187
12.1.5.4.1 Key strengths 187
12.1.5.4.2 Strategic choices 187
12.1.5.4.3 Weaknesses and competitive threats 187
12.1.6 CROMA PHARMA 188
12.1.6.1 Business overview 188
12.1.6.2 Products offered 188
12.1.7 EVOLUS, INC. 189
12.1.7.1 Business overview 189
12.1.7.2 Products offered 190
12.1.7.3 Recent developments 190
12.1.7.3.1 Product launches and approvals 190
12.1.8 HUGEL, INC. 191
12.1.8.1 Business overview 191
12.1.8.2 Products offered 192
12.1.9 MEDYTOX 193
12.1.9.1 Business overview 193
12.1.9.2 Products offered 194
12.1.10 BIOXIS PHARMACEUTICAL 195
12.1.10.1 Business overview 195
12.1.10.2 Products offered 195
12.1.11 ZIMMER MEDIZINSYSTEME GMBH 196
12.1.11.1 Business overview 196
12.1.11.2 Products offered 196
12.1.12 CUTERA, INC. 197
12.1.12.1 Business overview 197
12.1.12.2 Products offered 198
12.1.12.3 Recent developments 198
12.1.12.3.1 Product launches and approvals 198
12.1.12.3.2 Deals 198
12.1.13 SCIVISION BIOTECH INC. 199
12.1.13.1 Business overview 199
12.1.13.2 Products offered 200
12.1.14 BRIDGEPOINT GROUP PLC 201
12.1.14.1 Business overview 201
12.1.14.2 Products offered 201
12.1.15 ANIKA THERAPEUTICS, INC. 202
12.1.15.1 Business overview 202
12.1.15.2 Products offered 203
12.2 OTHER PLAYERS 204
12.2.1 TIGER AESTHETICS MEDICAL 204
12.2.2 PROLLENIUM MEDICAL TECHNOLOGIES 205
12.2.3 BIOSCIENCE GMBH 206
12.2.4 DERMAX 207
12.2.5 TEOXANE 208
12.2.6 DR. KORMAN LABORATORIES LTD. 209
12.2.7 CYTOPHIL, INC. 210
12.2.8 TELETA PHARMA 211
12.2.9 IBSA DERMA 212
12.2.10 NEOGENESIS 213
12.2.11 CGBIO, CO., LTD. 214
13 APPENDIX 215
13.1 DISCUSSION GUIDE 215
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 219
13.3 CUSTOMIZATION OPTIONS 221
13.4 RELATED REPORTS 221
13.5 AUTHOR DETAILS 222
圖表清單 List of Tables & Figures
TABLE 1 DERMA FILLERS MARKET: INCLUSIONS AND EXCLUSIONS 25
TABLE 2 STANDARD CURRENCY CONVERSION RATES, 2021–2023 26
TABLE 3 DERMA FILLERS MARKET: RISK ANALYSIS 42
TABLE 4 AVERAGE SELLING PRICE TREND OF HYALURONIC ACID FILLERS,
BY KEY PLAYER, 2022–2024 (USD) 56
TABLE 5 AVERAGE SELLING PRICE TREND OF DERMA FILLER PRODUCTS,
BY REGION, 2022–2024 (USD) 58
TABLE 6 DERMA FILLERS MARKET: ROLE OF COMPANIES IN ECOSYSTEM 62
TABLE 7 DERMA FILLERS MARKET: INNOVATIONS AND PATENT REGISTRATIONS,
2022–2024 67
TABLE 8 IMPORT DATA FOR HS CODE 330499, BY COUNTRY,
2020–2024 (USD THOUSAND) 68
TABLE 9 EXPORT DATA FOR HS CODE 611510, BY COUNTRY,
2020–2024 (USD THOUSAND) 69
TABLE 10 DERMA FILLERS MARKET: KEY CONFERENCES AND EVENTS, 2025–2026 70
TABLE 11 US FDA: MEDICAL DEVICE CLASSIFICATION 72
TABLE 12 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 76
TABLE 13 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 76
TABLE 14 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 77
TABLE 15 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 77
TABLE 16 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 77
TABLE 17 DERMA FILLERS MARKET: PORTER’S FIVE FORCES ANALYSIS 78
TABLE 18 KEY REQUIREMENTS OF STAKEHOLDERS WHILE BUYING DERMA FILLERS 80
TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF DERMA FILLERS,
BY PRODUCT TYPE (%) 81
TABLE 20 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER 81
TABLE 21 REIMBURSEMENT CODES FOR VARIOUS PROCEDURES 82
TABLE 22 UNMET CUSTOMER NEEDS AND KEY PAIN POINTS 82
TABLE 23 US ADJUSTED RECIPROCAL TARIFF RATES 85
TABLE 24 DERMA FILLERS MARKET, BY BRAND, 2023–2030 (USD MILLION) 89
TABLE 25 DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 94
TABLE 26 NATURAL DERMAL FILLERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 94
TABLE 27 NORTH AMERICA: NATURAL DERMAL FILLERS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 95
TABLE 28 EUROPE: NATURAL DERMAL FILLERS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 95
TABLE 29 ASIA PACIFIC: NATURAL DERMAL FILLERS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 96
TABLE 30 LATIN AMERICA: NATURAL DERMAL FILLERS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 96
TABLE 31 MIDDLE EAST & AFRICA: NATURAL DERMAL FILLERS MARKET,
BY REGION, 2023–2030 (USD MILLION) 97
TABLE 32 NATURAL DERMAL FILLERS MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 97
TABLE 33 NATURAL DERMAL FILLERS MARKET, BY END USER, 2023–2030 (USD MILLION) 97
TABLE 34 HYALURONIC ACID FILLERS MARKET, BY REGION, 2023–2030 (USD MILLION) 98
TABLE 35 COLLAGEN FILLERS MARKET, BY REGION, 2023–2030 (USD MILLION) 99
TABLE 36 SYNTHETIC DERMAL FILLERS MARKET, BY TYPE, 2023–2030 (USD MILLION) 99
TABLE 37 NORTH AMERICA: SYNTHETIC DERMAL FILLERS MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 100
TABLE 38 EUROPE: SYNTHETIC DERMAL FILLERS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 100
TABLE 39 ASIA PACIFIC: SYNTHETIC DERMAL FILLERS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 101
TABLE 40 LATIN AMERICA: SYNTHETIC DERMAL FILLERS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 101
TABLE 41 MIDDLE EAST & AFRICA: SYNTHETIC DERMAL FILLERS MARKET,
BY REGION, 2023–2030 (USD MILLION) 102
TABLE 42 SYNTHETIC DERMAL FILLERS MARKET, BY PROCEDURE,
2023–2030 (USD MILLION) 102
TABLE 43 SYNTHETIC DERMAL FILLERS MARKET, BY END USER, 2023–2030 (USD MILLION) 102
TABLE 44 CALCIUM HYDROXYLAPATITE (CAHA) FILLERS MARKET,
BY REGION, 2023–2030 (USD MILLION) 103
TABLE 45 POLY-L-LACTIC ACID (PLLA) FILLERS MARKET, BY REGION,
2023–2030 (USD MILLION) 104
TABLE 46 POLYMETHYL METHACRYLATE (PMMA) FILLERS MARKET,
BY REGION, 2023–2030 (USD MILLION) 104
TABLE 47 POLYNUCLEOTIDE FILLERS MARKET, BY REGION, 2023–2030 (USD MILLION) 105
TABLE 48 OTHER SYNTHETIC FILLERS MARKET, BY REGION, 2023–2030 (USD MILLION) 106
TABLE 49 DERMA FILLERS MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 108
TABLE 50 DERMA FILLERS MARKET FOR SKIN REJUVENATION,
BY REGION, 2023–2030 (USD MILLION) 109
TABLE 51 DERMA FILLERS MARKET FOR FACE & BODY CONTOURING,
BY REGION, 2023–2030 (USD MILLION) 110
TABLE 52 DERMA FILLERS MARKET FOR LIP AUGMENTATION, BY REGION,
2023–2030 (USD MILLION) 110
TABLE 53 DERMA FILLERS MARKET FOR OTHER PROCEDURES, BY REGION,
2023–2030 (USD MILLION) 111
TABLE 54 DERMA FILLERS MARKET, BY END USER, 2023–2030 (USD MILLION) 113
TABLE 55 DERMA FILLERS MARKET FOR DERMATOLOGY CLINICS & HOSPITALS,
BY REGION, 2023–2030 (USD MILLION) 114
TABLE 56 DERMA FILLERS MARKET FOR BEAUTY CENTERS, BY REGION,
2023–2030 (USD MILLION) 115
TABLE 57 DERMA FILLERS MARKET FOR MEDICAL SPAS, BY REGION,
2023–2030 (USD MILLION) 116
TABLE 58 DERMA FILLERS MARKET FOR OTHER END USERS,
BY REGION, 2023–2030 (USD MILLION) 116
TABLE 59 DERMA FILLERS MARKET, BY REGION, 2023–2030 (USD MILLION) 118
TABLE 60 GLOBAL DERMA FILLERS PROCEDURE, 2021–2023 118
TABLE 61 NORTH AMERICA: MACROECONOMIC OUTLOOK 120
TABLE 62 NORTH AMERICA: DERMA FILLERS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 120
TABLE 63 NORTH AMERICA: DERMA FILLERS MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 121
TABLE 64 NORTH AMERICA: NATURAL DERMAL FILLERS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 121
TABLE 65 NORTH AMERICA: SYNTHETIC DERMAL FILLERS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 121
TABLE 66 NORTH AMERICA: DERMA FILLERS MARKET, BY PROCEDURE,
2023–2030 (USD MILLION) 122
TABLE 67 NORTH AMERICA: DERMA FILLERS MARKET, BY END USER,
2023–2030 (USD MILLION) 122
TABLE 68 US: DERMA FILLER PROCEDURES, 2021–2023 123
TABLE 69 US: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 123
TABLE 70 CANADA: DERMA FILLERS MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 124
TABLE 71 EUROPE: DERMA FILLERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 124
TABLE 72 EUROPE: DERMA FILLERS MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 125
TABLE 73 EUROPE: NATURAL DERMAL FILLERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 125
TABLE 74 EUROPE: SYNTHETIC DERMAL FILLERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 125
TABLE 75 EUROPE: DERMA FILLERS MARKET, BY PROCEDURE, 2023–2030 (USD MILLION) 126
TABLE 76 EUROPE: DERMA FILLERS MARKET, BY END USER, 2023–2030 (USD MILLION) 126
TABLE 77 EUROPE: MACROECONOMIC OUTLOOK 127
TABLE 78 GERMANY: DERMA FILLER PROCEDURES, 2021–2023 127
TABLE 79 GERMANY: DERMA FILLERS MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 128
TABLE 80 UK: DERMA FILLER PROCEDURES, 2022–2023 128
TABLE 81 UK: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 128
TABLE 82 FRANCE: DERMA FILLER PROCEDURES, 2023 129
TABLE 83 FRANCE: DERMA FILLERS MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 129
TABLE 84 ITALY: DERMA FILLER PROCEDURES, 2021–2023 130
TABLE 85 ITALY: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 130
TABLE 86 SPAIN: DERMA FILLER PROCEDURES, 2021–2023 131
TABLE 87 SPAIN: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 131
TABLE 88 REST OF EUROPE: DERMA FILLERS MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 132
TABLE 89 ASIA PACIFIC: MACROECONOMIC OUTLOOK 134
TABLE 90 ASIA PACIFIC: DERMA FILLERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 135
TABLE 91 ASIA PACIFIC: DERMA FILLERS MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 135
TABLE 92 ASIA PACIFIC: NATURAL DERMAL FILLERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 135
TABLE 93 ASIA PACIFIC: SYNTHETIC DERMAL FILLERS MARKET, BY TYPE,
2023–2030 (USD MILLION) 136
TABLE 94 ASIA PACIFIC: DERMA FILLERS MARKET, BY PROCEDURE,
2023–2030 (USD MILLION) 136
TABLE 95 ASIA PACIFIC: DERMA FILLERS MARKET, BY END USER,
2023–2030 (USD MILLION) 137
TABLE 96 JAPAN: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 137
TABLE 97 CHINA: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 138
TABLE 98 INDIA: DERMA FILLER PROCEDURES, 2021–2023 139
TABLE 99 INDIA: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 139
TABLE 100 AUSTRALIA: DERMA FILLERS MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 139
TABLE 101 SOUTH KOREA: DERMA FILLERS MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 140
TABLE 102 REST OF ASIA PACIFIC: DERMA FILLERS MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 141
TABLE 103 LATIN AMERICA: DERMA FILLERS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 141
TABLE 104 LATIN AMERICA: DERMA FILLERS MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 142
TABLE 105 LATIN AMERICA: NATURAL DERMAL FILLERS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 142
TABLE 106 LATIN AMERICA: SYNTHETIC DERMAL FILLERS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 142
TABLE 107 LATIN AMERICA: DERMA FILLERS MARKET, BY PROCEDURE,
2023–2030 (USD MILLION) 143
TABLE 108 LATIN AMERICA: DERMA FILLERS MARKET, BY END USER,
2023–2030 (USD MILLION) 143
TABLE 109 LATIN AMERICA: MACROECONOMIC OUTLOOK 144
TABLE 110 BRAZIL: DERMA FILLER PROCEDURES, 2021–2023 144
TABLE 111 BRAZIL: DERMA FILLERS MARKET, BY PRODUCT TYPE, 2023–2030 (USD MILLION) 145
TABLE 112 MEXICO: DERMA FILLER PROCEDURES, 2021–2023 145
TABLE 113 MEXICO: DERMA FILLERS MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 146
TABLE 114 REST OF LATIN AMERICA: DERMA FILLERS MARKET,
BY PRODUCT TYPE, 2023–2030 (USD MILLION) 146
TABLE 115 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK 148
TABLE 116 MIDDLE EAST & AFRICA: DERMA FILLERS MARKET, BY REGION,
2023–2030 (USD MILLION) 148
TABLE 117 MIDDLE EAST & AFRICA: DERMA FILLERS MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 148
TABLE 118 MIDDLE EAST & AFRICA: NATURAL DERMAL FILLERS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 149
TABLE 119 MIDDLE EAST & AFRICA: SYNTHETIC DERMAL FILLERS MARKET,
BY TYPE, 2023–2030 (USD MILLION) 149
TABLE 120 MIDDLE EAST & AFRICA: DERMA FILLERS MARKET, BY PROCEDURE,
2023–2030 (USD MILLION) 150
TABLE 121 MIDDLE EAST & AFRICA: DERMA FILLERS MARKET, BY END USER,
2023–2030 (USD MILLION) 150
TABLE 122 GCC COUNTRIES: DERMA FILLERS MARKET, BY PRODUCT TYPE,
2023–2030 (USD MILLION) 151
TABLE 123 REST OF MIDDLE EAST & AFRICA: DERMA FILLERS MARKET,
BY PRODUCT TYPE, 2023–2030 (USD MILLION) 151
TABLE 124 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES IN DERMA FILLERS MARKET, JANUARY 2022–MAY 2025 152
TABLE 125 DERMA FILLERS MARKET: DEGREE OF COMPETITION 156
TABLE 126 DERMA FILLERS MARKET: REGION FOOTPRINT 162
TABLE 127 DERMA FILLERS MARKET: PRODUCT TYPE FOOTPRINT 163
TABLE 128 DERMA FILLERS MARKET: PROCEDURE FOOTPRINT 164
TABLE 129 DERMA FILLERS MARKET: END-USER FOOTPRINT 165
TABLE 130 DERMA FILLERS MARKET: DETAILED LIST OF KEY STARTUPS/SMES 167
TABLE 131 DERMA FILLERS MARKET: COMPETITIVE BENCHMARKING OF
KEY STARTUPS/SMES 168
TABLE 132 DERMA FILLERS MARKET: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2021–MAY 2025 169
TABLE 133 DERMA FILLERS MARKET: DEALS, JANUARY 2021–MAY 2025 170
TABLE 134 ABBVIE INC.: COMPANY OVERVIEW 171
TABLE 135 ABBVIE INC.: PRODUCTS OFFERED 172
TABLE 136 ABBVIE INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–MAY 2025 173
TABLE 137 GALDERMA: COMPANY OVERVIEW 175
TABLE 138 GALDERMA: PRODUCTS OFFERED 176
TABLE 139 GALDERMA: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–MAY 2025 177
TABLE 140 GALDERMA: DEALS, JANUARY 2021–MAY 2025 177
TABLE 141 GALDERMA: EXPANSIONS, JANUARY 2021–MAY 2025 178
TABLE 142 MERZ PHARMA: COMPANY OVERVIEW 179
TABLE 143 MERZ PHARMA: PRODUCTS OFFERED 180
TABLE 144 MERZ PHARMA: PRODUCT LAUNCHES AND APPROVALS,
JANUARY 2021–MAY 2025 180
TABLE 145 MERZ PHARMA: EXPANSIONS, JANUARY 2021–MAY 2024 181
TABLE 146 SILCLAIR PHARMA: COMPANY OVERVIEW 183
TABLE 147 SILCLAIR PHARMA: PRODUCTS OFFERED 184
TABLE 148 REVANCE: COMPANY OVERVIEW 185
TABLE 149 REVANCE: PRODUCTS OFFERED 185
TABLE 150 REVANCE: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–MAY 2025 186
TABLE 151 REVANCE: DEALS, JANUARY 2021–MAY 2025 186
TABLE 152 CROMA PHARMA: COMPANY OVERVIEW 188
TABLE 153 CROMA PHARMA: PRODUCTS OFFERED 188
TABLE 154 EVOLUS, INC.: COMPANY OVERVIEW 189
TABLE 155 EVOLUS, INC.: PRODUCTS OFFERED 190
TABLE 156 EVOLUS, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–MAY 2025 190
TABLE 157 HUGEL, INC.: COMPANY OVERVIEW 191
TABLE 158 HUGEL, INC.: PRODUCTS OFFERED 192
TABLE 159 MEDYTOX: COMPANY OVERVIEW 193
TABLE 160 MEDYTOX: PRODUCTS OFFERED 194
TABLE 161 BIOXIS PHARMACEUTICAL: COMPANY OVERVIEW 195
TABLE 162 BIOXIS PHARMACEUTICAL: PRODUCTS OFFERED 195
TABLE 163 ZIMMER MEDIZINSYSTEME GMBH: COMPANY OVERVIEW 196
TABLE 164 ZIMMER MEDIZINSYSTEME GMBH: PRODUCTS OFFERED 196
TABLE 165 CUTERA, INC.: COMPANY OVERVIEW 197
TABLE 166 CUTERA, INC.: PRODUCTS OFFERED 198
TABLE 167 CUTERA, INC.: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–MAY 2025 198
TABLE 168 CUTERA, INC.: DEALS, JANUARY 2021–MAY 2025 198
TABLE 169 SCIVISION BIOTECH INC.: COMPANY OVERVIEW 199
TABLE 170 SCIVISION BIOTECH INC.: PRODUCTS OFFERED 200
TABLE 171 BRIDGEPOINT GROUP PLC: COMPANY OVERVIEW 201
TABLE 172 BRIDGEPOINT GROUP PLC: PRODUCTS OFFERED 201
TABLE 173 ANIKA THERAPEUTICS, INC.: COMPANY OVERVIEW 202
TABLE 174 ANIKA THERAPEUTICS, INC.: PRODUCTS OFFERED 203
TABLE 175 TIGER AESTHETICS MEDICAL: COMPANY OVERVIEW 204
TABLE 176 PROLLENIUM MEDICAL TECHNOLOGIES: COMPANY OVERVIEW 205
TABLE 177 BIOSCIENCE GMBH: COMPANY OVERVIEW 206
TABLE 178 DERMAX: COMPANY OVERVIEW 207
TABLE 179 TEOXANE: COMPANY OVERVIEW 208
TABLE 180 DR. KORMAN LABORATORIES LTD.: COMPANY OVERVIEW 209
TABLE 181 CYTOPHIL, INC.: COMPANY OVERVIEW 210
TABLE 182 TELETA PHARMA: COMPANY OVERVIEW 211
TABLE 183 IBSA DERMA: COMPANY OVERVIEW 212
TABLE 184 NEOGENESIS: COMPANY OVERVIEW 213
TABLE 185 CGBIO, CO., LTD.: COMPANY OVERVIEW 214
FIGURE 1 DERMA FILLERS MARKET SEGMENTATION AND REGIONAL SCOPE 24
FIGURE 2 DERMA FILLERS MARKET: RESEARCH DESIGN 27
FIGURE 3 DERMA FILLERS MARKET: RESEARCH DATA 29
FIGURE 4 KEY PRIMARY SOURCES 31
FIGURE 5 SUPPLY- AND DEMAND-SIDE PARTICIPANTS 31
FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 32
FIGURE 7 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 34
FIGURE 8 MARKET SIZE ESTIMATION: COMPANY REVENUE ESTIMATION 35
FIGURE 9 DERMA FILLERS MARKET SIZE ESTIMATION METHODOLOGY 36
FIGURE 10 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 37
FIGURE 11 GROWTH RATE PROJECTIONS BASED ON MARKET DRIVERS 39
FIGURE 12 GROWTH RATE PROJECTIONS BASED ON MARKET OPPORTUNITIES,
RESTRAINTS, AND CHALLENGES 40
FIGURE 13 DATA TRIANGULATION 41
FIGURE 14 DERMA FILLERS MARKET, BY BRAND, 2025 VS. 2030 43
FIGURE 15 DERMA FILLERS MARKET, BY PRODUCT TYPE, 2025 VS. 2030 (USD MILLION) 44
FIGURE 16 DERMA FILLERS MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 44
FIGURE 17 DERMA FILLERS MARKET: GEOGRAPHIC SNAPSHOT (2024) 45
FIGURE 18 INCREASED AESTHETIC CONSCIOUSNESS AND RISING DISPOSABLE INCOME
TO DRIVE MARKET 46
FIGURE 19 SKIN REJUVENATION SEGMENT TO LEAD MARKET DURING FORECAST PERIOD 47
FIGURE 20 DERMATOLOGY CLINICS & HOSPITALS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 47
FIGURE 21 CHINA TO REGISTER HIGHEST CAGR FROM 2025 TO 2030 48
FIGURE 22 DERMA FILLERS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 49
FIGURE 23 NEW REVENUE POCKETS FOR PLAYERS IN DERMA FILLERS MARKET 54
FIGURE 24 AVERAGE SELLING PRICE TREND OF DERMA FILLER PRODUCTS,
BY TYPE, 2022–2024 (USD) 55
FIGURE 25 AVERAGE SELLING PRICE TREND OF HYALURONIC ACID FILLERS,
BY KEY PLAYER, 2022–2024 (USD) 56
FIGURE 26 AVERAGE SELLING PRICE TREND OF DERMA FILLER PRODUCTS,
BY REGION, 2022–2024 (USD) 57
FIGURE 27 DERMA FILLERS MARKET: VALUE CHAIN ANALYSIS 59
FIGURE 28 DERMA FILLERS MARKET: SUPPLY CHAIN ANALYSIS 61
FIGURE 29 DERMA FILLERS MARKET: ECOSYSTEM ANALYSIS 62
FIGURE 30 INVESTMENT AND FUNDING SCENARIO, 2019–2023 (USD MILLION) 63
FIGURE 31 NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 63
FIGURE 32 VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 (USD MILLION) 64
FIGURE 33 DERMA FILLERS MARKET: PATENT ANALYSIS, 2014–2024 66
FIGURE 34 DERMA FILLERS MARKET: IMPORT SCENARIO FOR HS CODE 330499,
BY COUNTRY, 2020–2024 (USD THOUSAND) 68
FIGURE 35 DERMA FILLERS MARKET: EXPORT SCENARIO FOR HS CODE 330499,
BY COUNTRY, 2020–2024 (USD THOUSAND) 69
FIGURE 36 DERMA FILLERS MARKET: PORTER’S FIVE FORCES ANALYSIS 78
FIGURE 37 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF DERMA FILLERS,
BY PRODUCT TYPE 80
FIGURE 38 KEY BUYING CRITERIA FOR TOP THREE END USERS 81
FIGURE 39 NORTH AMERICA: DERMA FILLERS MARKET SNAPSHOT 119
FIGURE 40 ASIA PACIFIC: DERMA FILLERS MARKET SNAPSHOT 133
FIGURE 41 REVENUE ANALYSIS OF KEY PLAYERS IN DERMA FILLERS MARKET, 2020–2024 154
FIGURE 42 NATURAL DERMAL FILLERS MARKET SHARE ANALYSIS, 2024 155
FIGURE 43 SYNTHETIC DERMA FILLERS MARKET SHARE ANALYSIS, 2024 155
FIGURE 44 EV/EBITDA OF KEY VENDORS 158
FIGURE 45 5-YEAR STOCK BETA OF KEY VENDORS 158
FIGURE 46 DERMA FILLERS MARKET: BRAND/PRODUCT COMPARISON 159
FIGURE 47 DERMA FILLERS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 160
FIGURE 48 DERMA FILLERS MARKET: COMPANY FOOTPRINT 161
FIGURE 49 DERMA FILLERS MARKET: COMPANY EVALUATION MATRIX
(STARTUPS/SMES), 2024 166
FIGURE 50 ABBVIE INC.: COMPANY SNAPSHOT (2024) 172
FIGURE 51 GALDERMA: COMPANY SNAPSHOT (2024) 176
FIGURE 52 EVOLUS, INC.: COMPANY SNAPSHOT (2024) 190
FIGURE 53 HUGEL, INC.: COMPANY SNAPSHOT (2024) 192
FIGURE 54 MEDYTOX: COMPANY SNAPSHOT (2024) 194
FIGURE 55 SCIVISION BIOTECH INC.: COMPANY SNAPSHOT (2024) 200
FIGURE 56 ANIKA THERAPEUTICS, INC.: COMPANY SNAPSHOT (2024) 203
同分類最新報告（醫療與生命科學）
查看醫療與生命科學全部報告 →
量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們